We would love to hear your thoughts about our site and services, please take our survey here.
Onwards and upwards
More good news, Oncimmune's US distributor signs 4 new four private payers insurance coverage of approximately 4.5 million people.
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test - link below
https://investors.biodesix.com/news-releases/news-release-details/biodesix-announces-first-four-private-payer-coverage-policies
Certain directors intending to subscribe for £1.2mln- I am guessing a large proportion of that is from the new Chairman Alistair. I guessing the new appointed non-exe director John Goold who just started a new fund listed on LSE will also invest. This looks like insiders taking a position before the company reaches inflexion point next year with EarlyCDT Lung expected to grow significantly over the short-term as Biodesix their US distributor raises $90mil to fund expansion. I have high hopes for this one 12 months from now. GLA, DYOR, IMO.
Good question Gamblors, I did not find the royalty numbers. But it does say Biodesix will pay Oncimmune a total of $28 million over five years. I am guessing this is equivalent to the licensing rights for EarlyCDT excluding COGS and Royalty.
https://www.fiercebiotech.com/medtech/biodesix-acquires-oncimmune-s-u-s-lab-for-rule-lung-nodule-cancer-blood-test
Biodesix which is Oncimmune's USA distributor of EarlyCDT Lung raised $40m equity + $50m debt totalling $90m to drive commercial sales of their core lung-diagnostic business which mainly consists of Oncimmune's EarlyCDT Lung rights. This hopefully will drive sales and bring more royalty payments to Oncimmune.
I am hoping Adam Hill and his team can deliver some positive news to drive up the share price so we can raise some capital to further invest in the business. IMO , DYOR
It would be very meaningful if Chairman decides to have skin in the game. He's LOADED. At current market cap, he could probably afford to buy out the company by himself, not saying he would but just to mention his compensation at Syneos as CEO was around £6-8mil per year. A serious several £million investment in ONC would definitely align interests and bring excitement for all shareholders. I hope he is not passive in taking this company to the next growth stages. A small company like Oncimmune requires his help to wisdom, expertise and most importantly action.
They are not desperate to raise funds currently but I guess if the right investor (s) comes along with interest, then it's always good to have more money to invest in growth, hopefully can raise capital at a premium rather than a discount like previously. IMO, DYOR
Good news, it's now the 3rd deal in 5 years. It does demonstrate they have the tech and ability to make good deals. But like previous deals, there has been a pattern, after every deal so far has been followed by a fund raise. The issue with this business model is it relies heavily on upfront payment (2m for this deal)+ milestone payments and then royalty on sales which will takes a long time/many years. Therefore C4x will need to keep raising funds to maintain operations and invest until they have many potential assets in the pipeline. IMO, DYOR.
Are retail investors going to get wiped out? Follows a similar pattern to the most recent rights issue. Appalling.
Looks like Jim has lost interest in continuously funding this project when we are facing long timelines to production. The reality is, it is very difficult, timely and costly to get gold in scale from these mines. Cut loses and move on. If he is confident in a big return, he won't sell now after all these years of investment.. IMO, DYOR.
New CEO, looks like a good appointment. Opening markets positive
Mr Diamond is going to have to pick up the phone to Qatar friend's for more oil money if he wants this deal done. I think he needs at least 40p+ (£60mil) to convince the board. IMO, DYOR.
Meagre deal indeed, I am doubtful Sam Smith would agree considering she bought 350k shares at 31p in Feb 2022 and also it is her "Baby"; so I think anything south of 30p is pretty lame offer IMO, DYOR.
20p a share... only 10% more than current levels. Not so attractive for shareholders.
https://news.sky.com/story/diamonds-panmure-in-talks-about-37m-takeover-of-finncap-12748897
An interesting company BUT the prior results tell the story reflected in the share price. Not much cash in the bank and a lot of debt. IMO, if don't get a fund raise soon, they are heading to big trouble. Not easy to raise capital in these economic environments. Hope they are able to raise without a significant discount. IMO, DYOR.
-Revenue £3.86M
-Loss £9.90M
-Share-based payments £1.80M
-Cash £2.53M
-net debt £8.16M
IMO Panmure + Finncap makes good strategic fit. But Panmure needs to offer attractive too good to turn down deal to convince the board and the shareholders. Not sure how badly Panmure wants to buy Finncap but I would think at least 30p+ would be at all considered. Any lower would be meaningless.. Sam Smith ex-CEO bought at 31p this year... DYOR, IMO.
Any money leftover will be used to pay fat redundancies packages and goodbye parties... and not to shareholders. The board did not really care about the "greedy" shareholders, besides they will prioritise setting a side any refunding of any customers, warranties and their suppliers. As well as paying any creditors. After all this, there will be nothing left for shareholders. Benson obviously didn't pay much which is why it wasn't disclosed either and they left it to last minute after admin to get a good deal. It's been a wild ride on this board. Thanks all for being on the journey together although a car crash definitely a lesson for me in particular wanna thank Wyn, Geeman and others I've missed for their valued contribution to the board. GL to you all.
Who is selling this? The constant sells over a long period I sense a particular II is exiting.
It would be good if Matt could just spare 20m from his annual rent income from his property income from THG and buy out the remaining 5% Jupiter's stake... This would help to relief the constant selling and downward path we have here. And then another 20m to prop the share price up! C'mon Matt. IMO, DYOR.